Insights from the ESMO Targeted Anticancer Therapies Asia Congress 2026

Nature Cancer · Published 2026-08-05 · DOI 10.1038/s43018-026-01215-1

Authors (1)

Vincenzo Giacco

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Giacco, V. (2026). Insights from the ESMO Targeted Anticancer Therapies Asia Congress 2026. Nature Cancer. https://doi.org/10.1038/s43018-026-01215-1

Related articles

• Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study · Nature Cancer · 2026 · Same journal
• GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells · Nature Cancer · 2026 · Same journal
• PAPOLA-mediated hyperactive polyadenylation promotes leukemogenesis and leukemia stem cell self-renewal through metabolic reprogramming · Nature Cancer · 2026 · Same journal
• Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial · Nature Cancer · 2026 · Same journal
• Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases · Nature Cancer · 2026 · Same journal
• Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironment · Nature Cancer · 2026 · Same journal
• Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity · Nature Cancer · 2026 · Same journal
• Bacterial engineering for cancer therapy · Nature Cancer · 2026 · Same journal
• A high-MAPK, low-WNT cell state drives metastatic dissemination in colorectal cancer · Nature Cancer · 2026 · Same journal
• DeepFAN, a transformer-based model for human–artificial intelligence collaborative assessment of incidental pulmonary nodules in CT scans: a multireader, multicase trial · Nature Cancer · 2026 · Same journal